[HTML][HTML] Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolasevic, S Stojsavljevic, F Blazic… - World Journal of …, 2021 - ncbi.nlm.nih.gov
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved short-term graft and …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolašević, S Stojsavljević, F Blažić… - World Journal of …, 2021 - repozitorij.kb-merkur.hr
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved shortterm graft and …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolašević, S Stojsavljević, F Blazic… - World Journal of …, 2021 - dabar.srce.hr
Abstract (english) In the last two decades, advances in immunosuppressive regimens have
led to fewer complications of acute rejection crisis and consequently improved short-term …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolašević, S Stojsavljević… - World Journal of …, 2021 - unirepository.svkri.uniri.hr
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved shortterm graft and …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolašević, S Stojsavljević, F Blažić… - World Journal of …, 2021 - repository.medri.uniri.hr
Abstract (english) In the last two decades, advances in immunosuppressive regimens have
led to fewer complications of acute rejection crisis and consequently improved short-term …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation-Where do we stand?

I Mikolasevic, S Stojsavljevic… - World journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved short-term graft and …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolašević, S Stojsavljević, F Blazic… - World Journal of …, 2021 - repozitorij.unizg.hr
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved shortterm graft and …

[HTML][HTML] Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolasevic, S Stojsavljevic, F Blazic, M Mijic… - World Journal of …, 2021 - wjgnet.com
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved short-term graft and …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation–Where do we stand?

I Mikolašević, S Stojsavljević, F Blazic… - World Journal of …, 2021 - repozitorij.mef.unizg.hr
Abstract (english) In the last two decades, advances in immunosuppressive regimens have
led to fewer complications of acute rejection crisis and consequently improved short-term …

Noninvasive markers of liver steatosis and fibrosis after liver transplantation-Where do we stand?

I Mikolasevic, S Stojsavljevic, F Blazic… - World Journal of …, 2021 - europepmc.org
In the last two decades, advances in immunosuppressive regimens have led to fewer
complications of acute rejection crisis and consequently improved short-term graft and …